News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Reuters171d agoneutral
Hims offers Apotex's generic semaglutide in Canada after Novo patent expiryMarketWatch173d agoneutral
Some people lose far more weight than others on GLP-1s like Wegovy. Here’s why.Investor's Business Daily180d agoneutral
Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In ObesityThe Wall Street Journal181d agoneutral
Hims & Hers Health Swings to First-Quarter Loss as Expenses RiseThe Wall Street Journal184d agoneutral
Sandoz CEO Says Size of Weight-Loss Generics Market Is UnknownReuters185d agoneutral
Analysis-Novo and Lilly gain on signs weight-loss pills could expand the marketBarrons.com186d agoneutral
Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.